752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial.
Saved in:
| Title: | 752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial. |
|---|---|
| Authors: | Le Saux, O.1 (AUTHOR), Borel, C.2 (AUTHOR), Ghiringhelli, F.3 (AUTHOR), Bigot, F.4 (AUTHOR), Vansteene, D.5 (AUTHOR), Chaltiel, R.6 (AUTHOR), Cousin, S.7 (AUTHOR), Durando, X.8 (AUTHOR), Coquan, E.9 (AUTHOR), Abdeddaim, C.10 (AUTHOR), Jeannot, E.11 (AUTHOR), Guerini Rocco, E.12 (AUTHOR), Frige, G.13 (AUTHOR), Francisco, M.14 (AUTHOR), Halladjian, M.14 (AUTHOR), Kamal, M.15 (AUTHOR), Legrand, F.16 (AUTHOR), Jimenez, M.16 (AUTHOR), Cabarrou, B.17 (AUTHOR), Le Tourneau, C.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS515-S516. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173098779 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Le+Saux%2C+O%2E%22">Le Saux, O.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borel%2C+C%2E%22">Borel, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghiringhelli%2C+F%2E%22">Ghiringhelli, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bigot%2C+F%2E%22">Bigot, F.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vansteene%2C+D%2E%22">Vansteene, D.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chaltiel%2C+R%2E%22">Chaltiel, R.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cousin%2C+S%2E%22">Cousin, S.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durando%2C+X%2E%22">Durando, X.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Coquan%2C+E%2E%22">Coquan, E.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdeddaim%2C+C%2E%22">Abdeddaim, C.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jeannot%2C+E%2E%22">Jeannot, E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guerini+Rocco%2C+E%2E%22">Guerini Rocco, E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frige%2C+G%2E%22">Frige, G.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Francisco%2C+M%2E%22">Francisco, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halladjian%2C+M%2E%22">Halladjian, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kamal%2C+M%2E%22">Kamal, M.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Legrand%2C+F%2E%22">Legrand, F.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jimenez%2C+M%2E%22">Jimenez, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cabarrou%2C+B%2E%22">Cabarrou, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Tourneau%2C+C%2E%22">Le Tourneau, C.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS515-S516. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098779 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.1931 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S515 Titles: – TitleFull: 752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Le Saux, O. – PersonEntity: Name: NameFull: Borel, C. – PersonEntity: Name: NameFull: Ghiringhelli, F. – PersonEntity: Name: NameFull: Bigot, F. – PersonEntity: Name: NameFull: Vansteene, D. – PersonEntity: Name: NameFull: Chaltiel, R. – PersonEntity: Name: NameFull: Cousin, S. – PersonEntity: Name: NameFull: Durando, X. – PersonEntity: Name: NameFull: Coquan, E. – PersonEntity: Name: NameFull: Abdeddaim, C. – PersonEntity: Name: NameFull: Jeannot, E. – PersonEntity: Name: NameFull: Guerini Rocco, E. – PersonEntity: Name: NameFull: Frige, G. – PersonEntity: Name: NameFull: Francisco, M. – PersonEntity: Name: NameFull: Halladjian, M. – PersonEntity: Name: NameFull: Kamal, M. – PersonEntity: Name: NameFull: Legrand, F. – PersonEntity: Name: NameFull: Jimenez, M. – PersonEntity: Name: NameFull: Cabarrou, B. – PersonEntity: Name: NameFull: Le Tourneau, C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
